...
首页> 外文期刊>Strahlentherapie und Onkologie >Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results.
【24h】

Intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy : treatment feasibility and preliminary results.

机译:低能光子的术中放疗(IORT)可增强早期口腔癌患者的术后放疗适应症:治疗可行性和初步结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the feasibility and preliminary results of intraoperative radiotherapy (IORT) with low-energy photons as a boost in patients with early-stage oral cancer with the indications for postoperative radiotherapy. PATIENTS AND METHODS: Between 2003 and 2006, 16 patients with early-stage cancer of mobile tongue (n = 10 [63%]) or floor of the mouth (n = 6 [37%]) treated at Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland, were evaluated for IORT boost with the INTRABEAM(R)System (Carl Zeiss Surgical GmbH; IORT-PRS) because of the high risk of local recurrence due to positive margins on frozen pathologic section. After tumor resection, the applicator was positioned in the tumor bed. The applicator's diameter (range: 1.5-5 cm) was selected to encompass high-risk area of tumor recurrence. The dose (5 Gy, 7 Gy, or 7.5 Gy) was applied according to tumor volume and bone proximity. External-beam radiotherapy (EBRT) was provided to the tumor bed in all patients (50 Gy) and to the nodal area, when needed. Toxicity and local tumor control were assessed. RESULTS: Median follow-up was 36 months. IORT did not increase acute mucosal reaction. Local tumor control was found in all cases. Early mucosal reaction did not exceed 3 according to the RTOG scale and healed in median time of 35 days after completion of EBRT. No late adverse effects were observed. CONCLUSION: This preliminary report has demonstrated the feasibility of IORT-PRS for patients with early oral cancer with the indications for postoperative radiotherapy. This method may be considered an alternative boost technique, although additional studies are needed to establish long-term results in a larger group of patients.
机译:目的:评估低能光子术中放疗(IORT)在早期口腔癌患者中的可行性和初步结果,并提示术后放疗。患者与方法:2003年至2006年,Maria Sklodowska-Curie Memorial癌症治疗了16例早期活动性舌癌(n = 10 [63%])或口底部早期癌症(n = 6 [37%])。由于INTRABEAM(R)系统(Carl Zeiss Surgical GmbH; IORT-PRS),由于冷冻病理切片的切缘阳性而导致局部复发的风险很高,因此对波兰Gliwice Branch的肿瘤中心和研究所进行了IORT增强的评估。肿瘤切除后,将涂药器放置在肿瘤床上。选择涂药器的直径(范围:1.5-5 cm)以涵盖肿瘤复发的高风险区域。根据肿瘤的体积和骨骼的接近程度,使用剂量(5 Gy,7 Gy或7.5 Gy)。所有患者(50 Gy)的肿瘤床均需进行束外放疗(EBRT),必要时可提供淋巴结放疗。评估毒性和局部肿瘤控制。结果:中位随访时间为36个月。 IORT没有增加急性粘膜反应。在所有情况下均发现局部肿瘤控制。根据RTOG量表,早期粘膜反应不超过3次,并在EBRT完成后的35天内中位治愈。没有观察到后期不良反应。结论:该初步报告证明了IORT-PRS在早期口腔癌患者中的可行性,并具有术后放疗的适应症。尽管需要更多的研究来确定更多患者的长期结果,但该方法仍可被视为替代的加强技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号